(Q22306384)

2

George L

Bakris

1 reference

6 April 2023

H. R. Black

3

Henry R

Black

1 reference

6 April 2023

W. C. Cushman

4

William C

Cushman

1 reference

6 April 2023

L. A. Green

5

Lee A

Green

1 reference

6 April 2023

J. L. Izzo

6

Joseph L Jr

Izzo

1 reference

6 April 2023

D. W. Jones

7

Daniel W

Jones

1 reference

6 April 2023

B. J. Materson

8

Barry J

Materson

1 reference

6 April 2023

S. Oparil

9

Suzanne

Oparil

1 reference

6 April 2023

J. T. Wright

10

Jackson T Jr

Wright

1 reference

6 April 2023

E. J. Roccella

11

Edward J

Subgroup and per-protocol analysis of the randomized European Trial on Isolated Systolic Hypertension in the Elderly.

Roccella

1 reference

6 April 2023

language of work or name

English

0 references

publication date

1 December 2003

0 references

published in

Hypertension

0 references

volume

42

0 references

page(s)

1206-1252

0 references

issue

6

0 references

cites work

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

Type 2 diabetes mellitus: greater cardiovascular risks and greater benefits of therapy

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

Risk Factors for Stroke in Type 2 Diabetes Mellitus

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

Clustering of metabolic factors and coronary heart disease

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

The role of diastolic blood pressure when treating isolated systolic hypertension

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

Diuretics and beta-blockers do not have adverse effects at 1 year on plasma lipid and lipoprotein profiles in men with hypertension. Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

Improving preventive care by prompting physicians

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

Implications of a health lifestyle and medication analysis for improving hypertension control.

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

Regional and racial differences in response to antihypertensive medication use in a randomized controlled trial of men with hypertension in the United States. Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

Impact of overweight on the risk of developing common chronic diseases during a 10-year period

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

Effects of reduced sodium intake on hypertension control in older individuals: results from the Trial of Nonpharmacologic Interventions in the Elderly (TONE)

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

Are aneroid sphygmomanometers accurate in hospital and clinic settings?

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

Prevalence of high blood pressure and elevated serum creatinine level in the United States: findings from the third National Health and Nutrition Examination Survey (1988-1994).

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

Successful blood pressure control in the African American Study of Kidney Disease and Hypertension

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

Time trends in high blood pressure control and the use of antihypertensive medications in older adults: the Cardiovascular Health Study.

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988-1994.

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

Management of high blood pressure in African Americans: consensus statement of the Hypertension in African Americans Working Group of the International Society on Hypertension in Blacks.

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

Effects of blood pressure lowering with perindopril and indapamide therapy on dementia and cognitive decline in patients with cerebrovascular disease

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

Thiazide Therapy Is Not a Cause of Arrhythmia in Patients With Systemic Hypertension

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

Hypotensive responses to common daily activities in institutionalized elderly. A potential risk for recurrent falls

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

Beta-adrenergic blocker therapy does not worsen intermittent claudication in subjects with peripheral arterial disease. A meta-analysis of randomized controlled trials

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

Long-term effects of antihypertensive agents on proteinuria and renal function

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

Population-based study of sleep-disordered breathing as a risk factor for hypertension

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

Sclerosing vasculopathy of the central nervous system in nonelderly demented patients

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

Further observations on the pathology of subcortical lesions identified on magnetic resonance imaging

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

Magnetic resonance imaging cerebral abnormalities and neuropsychologic test performance in elderly hypertensive subjects. A case-control study.

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

White matter lesions and disequilibrium in older people. II. Clinicopathologic correlation

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

Current concepts in mild cognitive impairment

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

United Kingdom Prospective Diabetes Study, 30: diabetic retinopathy at diagnosis of non-insulin-dependent diabetes mellitus and associated risk factors.

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

A randomized trial of propranolol in patients with acute myocardial infarction. I. Mortality results

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

Health outcomes associated with antihypertensive therapies used as first-line agents. A systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

Why are physicians not prescribing diuretics more frequently in the management of hypertension?

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

Current and remote blood pressure and cognitive decline.

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

Low risk-factor profile and long-term cardiovascular and noncardiovascular mortality and life expectancy: findings for 5 large cohorts of young adult and middle-aged men and women

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

Dietary sodium intake and subsequent risk of cardiovascular disease in overweight adults

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

Predicting Cardiovascular Risk Using Conventional vs Ambulatory Blood Pressure in Older Patients With Systolic Hypertension

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

Association of sleep-disordered breathing, sleep apnea, and hypertension in a large community-based study. Sleep Heart Health Study

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

Longitudinal study of moderate weight change and sleep-disordered breathing

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

Physical activity and coronary heart disease in women: is "no pain, no gain" passé?

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

Epidemic increase in childhood overweight, 1986-1998.

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals.

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

Diuretic therapy, the alpha-adducin gene variant, and the risk of myocardial infarction or stroke in persons with treated hypertension

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

Residual lifetime risk for developing hypertension in middle-aged women and men: The Framingham Heart Study

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

Prevalence and Trends in Obesity Among US Adults, 1999-2000

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

Primary prevention of hypertension: clinical and public health advisory from The National High Blood Pressure Education Program

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

Effect of weight loss and lifestyle changes on vascular inflammatory markers in obese women: a randomized trial

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

Principal Results of the Controlled Onset Verapamil Investigation of Cardiovascular End Points (CONVINCE) Trial

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

Relationship of Changes in Physical Activity and Mortality Among Older Women

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

Health outcomes associated with various antihypertensive therapies used as first-line agents: a network meta-analysis

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure<SUBTITLE>The JNC 7 Report</SUBTITLE>

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

Measuring blood pressure accurately: new and persistent challenges

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease. The International Verapamil-Trandolapril Study (INVEST): a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000.

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

Relationship between plasma plasminogen activator inhibitor 1 and insulin resistance

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

Characteristics of inactive primary care patients: baseline data from the activity counseling trial. For the Activity Counseling Trial Research Group

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

Hypertension in multicultural and minority populations: linking communication to compliance.

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

Lifestyle factors and stroke risk: exercise, alcohol, diet, obesity, smoking, drug use, and stress.

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

Association of albuminuria and the metabolic syndrome

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

Insulin resistance and the sympathetic nervous system

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

Reflections on the sixth report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

Influence of heart rate on mortality among persons with hypertension: the Framingham Study

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

Blood pressure and coronary heart disease

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

Recommendations for the use of home (self) and ambulatory blood pressure monitoring. American Society of Hypertension Ad Hoc Panel

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

Metabolic syndrome and coronary angiographic disease progression: the Women's Angiographic Vitamin & Estrogen trial

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

Effects of celecoxib and rofecoxib on blood pressure and edema in patients > or =65 years of age with systemic hypertension and osteoarthritis

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

Pharmacokinetics, efficacy, and safety of analgesia with a focus on tramadol HCl.

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

The impact of ethnicity on response to antihypertensive therapy

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

Nephrotoxicity of nonsteroidal anti-inflammatory drugs: physiologic foundations and clinical implications

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

The association between orthostatic hypotension and recurrent falls in nursing home residents

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

Higher incidence of discontinuation of angiotensin converting enzyme inhibitors due to cough in black subjects

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

Black Americans have an increased rate of angiotensin converting enzyme inhibitor-associated angioedema

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

Doxazosin in benign prostatic hyperplasia: effects on blood pressure and urinary flow in normotensive and hypertensive men

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

Molecular mechanisms of human hypertension

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

Randomised trial of effects of calcium antagonists compared with diuretics and beta-blockers on cardiovascular morbidity and mortality in hypertension: the Nordic Diltiazem (NORDIL) study

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

Morbidity and mortality in patients randomised to double-blind treatment with a long-acting calcium-channel blocker or diuretic in the International Nifedipine GITS study: Intervention as a Goal in Hypertension Treatment (INSIGHT).

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomised trials. Blood Pressure Lowering Treatment Trialists' Collaboration

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

Blood-pressure lowering for the secondary prevention of stroke

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

Assessment of frequency of progression to hypertension in non-hypertensive participants in the Framingham Heart Study: a cohort study

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study).

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

Placebo-controlled comparison of captopril, atenolol, labetalol, and pindolol in hypertension complicated by intermittent claudication

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

Sleep apnoea and nocturnal angina.

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

Prevention of diabetic renal disease with special reference to microalbuminuria

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

Effect of renal-artery stenting on progression of renovascular renal failure

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators.

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial.

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

Fall in mean arterial pressure and fetal growth restriction in pregnancy hypertension: a meta-analysis

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

Antihypertensive drugs in very old people: a subgroup meta-analysis of randomised controlled trials. INDANA Group

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

Impact of sleep debt on metabolic and endocrine function

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

Risks of untreated and treated isolated systolic hypertension in the elderly: meta-analysis of outcome trials

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

Randomised trial of old and new antihypertensive drugs in elderly patients: cardiovascular mortality and morbidity the Swedish Trial in Old Patients with Hypertension-2 study

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

The prevalence and risk factors of retinal microvascular abnormalities in older persons: The Cardiovascular Health Study

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

Heart failure with preserved systolic function. A different natural history?

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

Level of kidney function as a risk factor for atherosclerotic cardiovascular outcomes in the community

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

ACC/AHA 2002 guideline update for the management of patients with chronic stable angina--summary article: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (Committee on the Management of Pat

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

Nocturnal ischemic events in patients with obstructive sleep apnea syndrome and ischemic heart disease: effects of continuous positive air pressure treatment.

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

Orthostatic hypotension

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

Motivational interviewing in health care settings. Opportunities and limitations

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

An evidence-based review of patient-centered behavioral interventions for hypertension

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

Counseling to promote a healthy diet in adults: a summary of the evidence for the U.S. Preventive Services Task Force

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

Standardized health plan reporting in four areas of preventive health care

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

Hyperinsulinemia: the missing link among oxidative stress and age-related diseases?

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

Association and linkage analysis of the alpha-adducin gene and blood pressure

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

Effect of sildenafil in patients with erectile dysfunction taking antihypertensive therapy. Sildenafil Study Group

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

Sexual activity in hypertensive men treated with valsartan or carvedilol: a crossover study

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

Association between the alpha-adducin Gly460Trp polymorphism and systolic blood pressure in familial combined hyperlipidemia

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

Ethnic differences in electrocardiographic criteria for left ventricular hypertrophy: the LIFE study. Losartan Intervention For Endpoint

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

Hypertension in blacks

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

Statement from the National High Blood Pressure Education Program: prevalence of hypertension

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

Clinical features and contemporary management of patients with low and preserved ejection fraction heart failure: baseline characteristics of patients in the Candesartan in Heart failure-Assessment of Reduction in Mortality and morbidity (CHARM) pro

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

Renovascular disease in older patients beginning renal replacement therapy

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

Conventional and ambulatory blood pressure and menopause in a prospective population study

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

Hypertension in women

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

Sexual activity in hypertensive men.

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

Effects of aggressive blood pressure control in normotensive type 2 diabetic patients on albuminuria, retinopathy and strokes

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

Impact of renal failure on the risk of myocardial infarction and death

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

Preserving renal function in adults with hypertension and diabetes: a consensus approach. National Kidney Foundation Hypertension and Diabetes Executive Committees Working Group

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

Leptin and renal disease

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

Relationship of renal function to homocysteine and lipoprotein(a) levels: the frequency of the combination of both risk factors in chronic renal impairment

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

The therapeutic challenge of systolic hypertension.

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

Drug therapy: vasodilator drugs in peripheral vascular disease

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

Single-drug therapy for hypertension in men. A comparison of six antihypertensive agents with placebo. The Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents.

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

The occurrence of sleep-disordered breathing among middle-aged adults

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

Diuretic therapy for hypertension and the risk of primary cardiac arrest

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

Tissue plasminogen activator for acute ischemic stroke

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. Trandolapril Cardiac Evaluation (TRACE) Study Group

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

Treatment of hypertension in pregnant women

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

Development and progression of renal disease in Pima Indians with non-insulin-dependent diabetes mellitus. Diabetic Renal Disease Study Group

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery. Multicenter Study of Perioperative Ischemia Research Group

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

The effect of digoxin on mortality and morbidity in patients with heart failure

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

The effect of nisoldipine as compared with enalapril on cardiovascular outcomes in patients with non-insulin-dependent diabetes and hypertension

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

Effect of beta-blockade on mortality among high-risk and low-risk patients after myocardial infarction

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

Inadequate Management of Blood Pressure in a Hypertensive Population

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

Effects of Calcium-Channel Blockade in Older Patients with Diabetes and Systolic Hypertension

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

Hypertension and antihypertensive therapy as risk factors for type 2 diabetes mellitus. Atherosclerosis Risk in Communities Study.

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

Antihypertensive therapy and the risk of type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

Prospective study of the association between sleep-disordered breathing and hypertension

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-Sodium Collaborative Research Group

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

Effect of carvedilol on survival in severe chronic heart failure

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

Clinical practice. Nephropathy in patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

Impact of high-normal blood pressure on the risk of cardiovascular disease

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

Characteristics of patients with uncontrolled hypertension in the United States.

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

Long-Term Trends in the Incidence of and Survival with Heart Failure

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

A comparison of outcomes with angiotensin-converting--enzyme inhibitors and diuretics for hypertension in the elderly.

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

Prognostic value of ambulatory blood-pressure recordings in patients with treated hypertension

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

Cardiovascular effects of continuous positive airway pressure in patients with heart failure and obstructive sleep apnea

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

Estrogen plus progestin and the risk of coronary heart disease

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

Adverse perinatal outcomes are significantly higher in severe gestational hypertension than in mild preeclampsia

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

A systematic review of cardiovascular effects of epinephrine on hypertensive dental patients

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

Dementia and disability outcomes in large hypertension trials: lessons learned from the systolic hypertension in the elderly program (SHEP) trial

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

Relation of sleep-disordered breathing to cardiovascular disease risk factors: the Sleep Heart Health Study

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

Fitness and fatness as predictors of mortality from all causes and from cardiovascular disease in men and women in the lipid research clinics study

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

Metabolic syndrome and development of diabetes mellitus: application and validation of recently suggested definitions of the metabolic syndrome in a prospective cohort study

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

Comparison of left ventricular mass and geometry in black and white patients with essential hypertension

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

Update on reversal of left ventricular hypertrophy in essential hypertension (a meta-analysis of all randomized double-blind studies until December 1996).

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

Heredity and obesity-associated hypertension: impact of hormonal characteristics and left ventricular mass.

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

Cyclooxygenase-2--specific inhibitors and cardiorenal function: a randomized, controlled trial of celecoxib and rofecoxib in older hypertensive osteoarthritis patients

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

Limitations of current validation protocols for home blood pressure monitors for individual patients

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

Emergency room management of hypertensive urgencies and emergencies

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

1 reference

7 January 2021

Success and predictors of blood pressure control in diverse North American settings: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT).

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

Leuko-araiosis and stroke: a case-control study.

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

beta blockade and intermittent claudication: placebo controlled trial of atenolol and nifedipine and their combination

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

Obtaining useful information from expert based sources

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

Value of low dose combination treatment with blood pressure lowering drugs: analysis of 354 randomised trials

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

Quantitative MRI findings and cognitive impairment among community dwelling elderly subjects

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

Deep white matter infarction: correlation of MR imaging and histopathologic findings

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

Increases in leptin levels, sympathetic drive, and weight gain in obstructive sleep apnea.

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

Pathophysiology of insulin resistance in human disease.

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

Elevated C-reactive protein in patients with obstructive sleep apnea.

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

Urinary Albumin Excretion Predicts Cardiovascular and Noncardiovascular Mortality in General Population

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

Effect of nasal continuous positive airway pressure treatment on blood pressure in patients with obstructive sleep apnea.

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

Morning surge in blood pressure as a predictor of silent and clinical cerebrovascular disease in elderly hypertensives: a prospective study

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

Sleep apnea and heart failure: Part I: obstructive sleep apnea

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

Obstructive Sleep Apnea and the Recurrence of Atrial Fibrillation

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

Sleep-disordered breathing and cardiovascular disease.

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

Detection of patients at risk for paroxysmal atrial fibrillation during sinus rhythm by P wave-triggered signal-averaged electrocardiogram

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

Effects of celecoxib on ambulatory blood pressure in hypertensive patients on ACE inhibitors

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

Treatment of cardiovascular and renal risk factors in the diabetic hypertensive

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

Hypertensive retinal vessel wall signs in a general older population: the Blue Mountains Eye Study

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

Controlled clinical trials of drug treatment for hypertension. A review

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

Treatment of hypertension in the elderly: I. Blood pressure and clinical changes. Results of a Department of Veterans Affairs Cooperative Study

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

Implications of the INTERSALT study

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

Long-term effects on sexual function of five antihypertensive drugs and nutritional hygienic treatment in hypertensive men and women. Treatment of Mild Hypertension Study (TOMHS)

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

Baseline Characteristics and Early Blood Pressure Control in the CONVINCE Trial.

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

Guidelines for the early management of patients with ischemic stroke: A scientific statement from the Stroke Council of the American Stroke Association.

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

ACC/AHA guideline update for perioperative cardiovascular evaluation for noncardiac surgery---executive summary a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1996

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Final Report

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

Sleep-disordered breathing and cardiovascular disease: cross-sectional results of the Sleep Heart Health Study.

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

Randomized placebo-controlled trial of continuous positive airway pressure on blood pressure in the sleep apnea-hypopnea syndrome.

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

Sleep apnea and cardiovascular disease

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

Sleep-disordered breathing and insulin resistance in middle-aged and overweight men.

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

Sympathetic neural mechanisms in obstructive sleep apnea.

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

Systolic blood pressure within an intermediate range may reduce memory loss in an elderly hypertensive cohort.

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

Microalbuminuria: marker of vascular dysfunction, risk factor for cardiovascular disease

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

Association of midlife blood pressure to late-life cognitive decline and brain morphology.

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

MRI white matter hyperintensities: three-year follow-up of the Austrian Stroke Prevention Study

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

Midlife vascular risk factors and late-life mild cognitive impairment: A population-based study

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

Longitudinal study of blood pressure and white matter hyperintensities: the EVA MRI Cohort.

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

Adiposity and cardiovascular risk factors in men with obstructive sleep apnea.

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

Body fat distribution and sleep apnea severity in women.

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

The association of hypertension and secondary cardiovascular disease with sleep-disordered breathing

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

Rationale for fixed-dose combinations in the treatment of hypertension: the cycle repeats

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

Diabetes trends in the U.S.: 1990-1998.

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

Low levels of leisure-time physical activity and cardiorespiratory fitness predict development of the metabolic syndrome

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

Treatment of hypertension in adults with diabetes

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

Renal artery angioplasty: technical results and clinical outcome in 320 patients

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

Two words to improve physician-patient communication: what else?

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

Do nonsteroidal anti-inflammatory drugs affect blood pressure? A meta-analysis

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

Effect of antihypertensive drug treatment on cardiovascular outcomes in women and men. A meta-analysis of individual patient data from randomized, controlled trials. The INDANA Investigators

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: the HOPE randomized trial.

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

Effects of diet and sodium intake on blood pressure: subgroup analysis of the DASH-sodium trial

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

Angiotensin-converting enzyme inhibitors and progression of nondiabetic renal disease. A meta-analysis of patient-level data

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

1 reference

7 January 2021

Effect of aerobic exercise on blood pressure: a meta-analysis of randomized, controlled trials

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

Sexual function in men older than 50 years of age: results from the health professionals follow-up study

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

Progression of chronic kidney disease: the role of blood pressure control, proteinuria, and angiotensin-converting enzyme inhibition: a patient-level meta-analysis

1 reference

https://api.crossref.org/works/10.1161%2F01.HYP.0000107251.49515.C2

7 January 2021

10.1161/01.HYP.0000107251.49515.C2

Identifiers

DOI

1 reference

Consolidated OpenCitations Corpus – April 2017

97195

97195

1 reference

Consolidated OpenCitations Corpus – April 2017

Consolidated OpenCitations Corpus – April 2017

1 reference